Lotus Pharmaceutical Co., Ltd. (1795.TW) Stock
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Lotus Pharmaceutical Co., Ltd.
Lotus Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, central nervous system, cardiovascular diseases, woman health, and anti-obesity. The company also engages in retail of clinical machines; biotech technological consulting services; sale of pharmaceuticals and medicinal chemical products; marketing activities; market planning and business information services; and consultancy services on health management, health technology, and trading information services. In addition, it offers management consultancy services; pharmaceutical regulatory affairs project management, and data collection and agency services; healthcare consultancy services and operates as a contract research organization. Lotus Pharmaceutical Co., Ltd. was incorporated in 1966 and is headquartered in Taipei City, Taiwan.
Lotus Pharmaceutical Co., Ltd. (1795.TW) stock trades at $176.00 with a market capitalization of $46.89B. The stock is valued at a price-to-earnings (P/E) ratio of 12.38, price-to-book of 1.95, price-to-sales of 1.65. Over the past 52 weeks the stock has ranged between $168.31 and $364.76, and currently trades 51.7% below its 52-week high. It pays a dividend yielding 1.42%.
On profitability, Lotus Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 16.86%, above the typical market range of roughly 12-15%, an operating margin of 26.49%, a net profit margin of 13.22%.
The balance sheet shows a debt-to-equity ratio of 2.40 (debt more than twice shareholders' equity), a current ratio of 1.46.
1795.TW has an average daily trading volume of 1,066,743 shares, a beta of 0.38 (historically less volatile than the overall market), 0.27B shares outstanding.
Official website: www.lotuspharm.com.tw
Lotus Pharmaceutical Co., Ltd. (1795.TW) — frequently asked questions
What is Lotus Pharmaceutical Co., Ltd. (1795.TW) stock price today?
Lotus Pharmaceutical Co., Ltd. (1795.TW) is currently trading at $176.00, down 2.76% today.
What is 1795.TW P/E ratio?
Lotus Pharmaceutical Co., Ltd.'s P/E ratio is 12.38. This is below the typical market average of roughly 18-22x. A low P/E can reflect a lower valuation, slower expected growth, or both.
What is 1795.TW return on equity (ROE)?
Lotus Pharmaceutical Co., Ltd.'s return on equity (ROE) is 16.86%. ROE measures net income relative to shareholders' equity. This is above the typical market range of roughly 12-15%.
What is Lotus Pharmaceutical Co., Ltd.'s market cap?
Lotus Pharmaceutical Co., Ltd. has a market capitalization of $46.89B.
Does 1795.TW pay a dividend?
Yes. Lotus Pharmaceutical Co., Ltd. currently yields 1.42%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 1795.TW carry?
Lotus Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 2.40. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 1795.TW's profit margin?
Lotus Pharmaceutical Co., Ltd. reports a net profit margin of 13.22% — the share of revenue left after every cost, including tax and interest.
What sector is 1795.TW in?
Lotus Pharmaceutical Co., Ltd. is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 1795.TW listed on?
Lotus Pharmaceutical Co., Ltd. trades on TAI under the ticker 1795.TW.
What is 1795.TW's 52-week range?
Over the last year Lotus Pharmaceutical Co., Ltd. has traded between $168.31 and $364.76.
Related Healthcare Stocks
Popular Stocks
Screens 1795.TW currently matches
On the figures above, Lotus Pharmaceutical Co., Ltd. passes the filters for 16 of our ready-made screens, among them Undervalued Stocks, Undervalued Large Cap Stocks, Dividend Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.